Medicine versus physiotherapy machine treatment for muscle pain of face.

Comparative assessment of efficacy of transcutaneous electrical nerve stimulation versus pharmacotherapy (drug combination of ibuprofen 400 mg, paracetamol 325 mg, chlorzoxazone 250 mg) in the treatment of patients with myofascial pain- A prospective randomised controlled trial. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068987

Enrollment

Registered

2024-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K088- Other specified disorders of teethand supporting structures

Interventions

Intervention1: Combination of non steroidal anti inflammatory drugs and muscle relaxant: Combination of Ibuprofen 400 mg, Paracetamol 325 mg and Chlorzoxazone 250 mg. Twice a day after meal for 7 day

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either gender above 21 years of age. 2. Patients having complaint of masticatory muscle pain. 3. Pain and tenderness in the masticatory muscles on palpation. 4. Patients who have not received any treatment for Myofascial pain, 3 months before the research participation.

Exclusion criteria

Exclusion criteria: 1. Pain of non-muscular origin (Dental, vascular or neural). 2. Patients presenting with tenderness of temporomandibular joint on palpation. 3. Completely edentulous patients or multiple missing teeth. 4. Patients having epileptic attacks and seizures. 5. Patients of known case of peptic ulcer. 6. Patients mentally retarded or having neuromuscular problem. 7. Patients on pacemakers, cochlear implants or metallic implants (as TENS can alter or adversely affect the function of pacemakers). 8. Patients with cardiac abnormalities (TENS can modify the cardiac impulse). 9. Pregnant patients (TENS is contraindicated because it can cause preterm labour). 10. Patients showing any allergy to lubricating gel used in TENS therapy. 11. Patients with known allergy to chlorzoxazone, ibuprofen, paracetamol will be excluded. 12. Patients who do not give informed consent will be excluded.

Design outcomes

Primary

Measure	Time frame
1. Mouth opening (measurement of interincisal distance in mm) 2. VAS score (using visual analogue scale ranging 0-10) 3. Clicking sound (whether present or absent Y/N)Timepoint: 8 weeks	—

Secondary

Measure	Time frame
Adverse effects and recurrence of painTimepoint: Once in a month	—

Countries

India

Contacts

Public ContactShah Nida Mujibur Rahman

Government Dental College & Hospital Mumbai

sonalikdm863@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026